Sung-Sun Cho

Chief Executive Officer at YUANTA 4 SPECIAL PURPOSE ACQUISITION CO., LTD.

68 year

Health Technology

Finance

Profile

Sung-Sun Cho is currently the Chief Executive Officer and Director at Yuanta 4 SPECIAL PURPOSE ACQUISITION Co., Ltd.
Prior to this, Mr. Cho was the Chief Executive Officer at ProCell Therapeutics, Inc.

Sung-Sun Cho active positions

Companies	Position	Start
YUANTA 4 SPECIAL PURPOSE ACQUISITION CO., LTD.	Chief Executive Officer	-

All active positions of Sung-Sun Cho

Former positions of Sung-Sun Cho

Companies	Position	End
ProCell Therapeutics, Inc. ProCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ProCell Therapeutics, Inc. develops protein-based therapeutics. It handles the research and development of biotherapeutics capable of entering cells through proprietary Macromolecule Intracellcellular Transduction Technologies (MITT) using a line-up of Macromolecule Transduction Domain (MTD). The company was founded on December 12, 2005 and is headquartered in Seoul, South Korea.	Chief Executive Officer	-

See the detail of Sung-Sun Cho's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Sung-Sun Cho's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
YUANTA 4 SPECIAL PURPOSE ACQUISITION CO., LTD.	Finance

Private companies	1
ProCell Therapeutics, Inc. ProCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ProCell Therapeutics, Inc. develops protein-based therapeutics. It handles the research and development of biotherapeutics capable of entering cells through proprietary Macromolecule Intracellcellular Transduction Technologies (MITT) using a line-up of Macromolecule Transduction Domain (MTD). The company was founded on December 12, 2005 and is headquartered in Seoul, South Korea.	Health Technology